These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26692440)

  • 1. Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Adenocarcinoma.
    Ohmoto A; Yachida S; Kubo E; Takai E; Suzuki M; Shimada K; Okusaka T; Morizane C
    Pancreas; 2016 Aug; 45(7):1056-61. PubMed ID: 26692440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in Japanese familial pancreatic cancer patients.
    Takai E; Yachida S; Shimizu K; Furuse J; Kubo E; Ohmoto A; Suzuki M; Hruban RH; Okusaka T; Morizane C; Furukawa T
    Oncotarget; 2016 Nov; 7(45):74227-74235. PubMed ID: 27732944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
    Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
    JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.
    Roberts NJ; Grant RC; Gallinger S; Klein AP;
    Genes Chromosomes Cancer; 2021 Aug; 60(8):559-564. PubMed ID: 33724601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years.
    Lüttges J; Stigge C; Pacena M; Klöppel G
    Cancer; 2004 Jan; 100(1):173-82. PubMed ID: 14692038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
    Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
    Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
    Hu C; Hart SN; Bamlet WR; Moore RM; Nandakumar K; Eckloff BW; Lee YK; Petersen GM; McWilliams RR; Couch FJ
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):207-11. PubMed ID: 26483394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
    Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
    Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.
    Bannon SA; Montiel MF; Goldstein JB; Dong W; Mork ME; Borras E; Hasanov M; Varadhachary GR; Maitra A; Katz MH; Feng L; Futreal A; Fogelman DR; Vilar E; McAllister F
    Cancer Prev Res (Phila); 2018 Nov; 11(11):679-686. PubMed ID: 30274973
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration.
    Karloski E; Dudley B; Diergaarde B; Blanco A; Everett JN; Levinson E; Rangarajan T; Stanich PP; Childers K; Brown S; Drogan C; Cavestro GM; Gordon K; Singh A; Simeone DM; Reich H; Kastrinos F; Zakalik D; Hampel H; Pearlman R; Gordon OK; Kupfer SS; Puzzono M; Zuppardo RA; Brand RE
    Cancer; 2024 Oct; 130(19):3297-3304. PubMed ID: 38809542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
    Ryu KH; Park S; Chun JW; Cho E; Choi J; Lee DE; Shim H; Kim YH; Han SS; Park SJ; Woo SM; Kong SY
    Cancer Res Treat; 2023 Oct; 55(4):1303-1312. PubMed ID: 37024097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
    Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S
    J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation.
    Uemura S; Matsubayashi H; Kiyozumi Y; Uesaka K; Yamamoto Y; Sasaki K; Abe M; Urakami K; Kusuhara M; Yamaguchi K
    Fam Cancer; 2018 Apr; 17(2):255-259. PubMed ID: 28755079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.
    Furniss CS; Yurgelun MB; Ukaegbu C; Constantinou PE; Lafferty CC; Talcove-Berko ER; Schwartz AN; Stopfer JE; Underhill-Blazey M; Kenner B; Nelson SH; Okumura S; Law S; Zhou AY; Coffin TB; Rodriguez NJ; Uno H; Ocean AJ; McAllister F; Lowy AM; Lippman SM; Klein AP; Madlensky L; Petersen GM; Garber JE; Goggins MG; Maitra A; Syngal S
    Cancer Prev Res (Phila); 2021 Nov; 14(11):1021-1032. PubMed ID: 34625409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma.
    Hu H; Zhu Y; Pu N; Burkhart RA; Burns W; Laheru D; Zheng L; He J; Goggins MG; Yu J
    J Am Coll Surg; 2020 Nov; 231(5):527-535.e14. PubMed ID: 32659497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
    Walker EJ; Carnevale J; Pedley C; Blanco A; Chan S; Collisson EA; Tempero MA; Ko AH
    Fam Cancer; 2019 Apr; 18(2):241-251. PubMed ID: 30267352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.
    Obazee O; Archibugi L; Andriulli A; Soucek P; Małecka-Panas E; Ivanauskas A; Johnson T; Gazouli M; Pausch T; Lawlor RT; Cavestro GM; Milanetto AC; Di Leo M; Pasquali C; Hegyi P; Szentesi A; Radu CE; Gheorghe C; Theodoropoulos GE; Bergmann F; Brenner H; Vodickova L; Katzke V; Campa D; Strobel O; Kaiser J; Pezzilli R; Federici F; Mohelnikova-Duchonova B; Boggi U; Lemstrova R; Johansen JS; Bojesen SE; Chen I; Jensen BV; Capurso G; Pazienza V; Dervenis C; Sperti C; Mambrini A; Hackert T; Kaaks R; Basso D; Talar-Wojnarowska R; Maiello E; Izbicki JR; Cuk K; Saum KU; Cantore M; Kupcinskas J; Palmieri O; Delle Fave G; Landi S; Salvia R; Fogar P; Vashist YK; Scarpa A; Vodicka P; Tjaden C; Iskierka-Jazdzewska E; Canzian F
    Int J Cancer; 2019 Aug; 145(3):686-693. PubMed ID: 30672594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.